Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Research Stakeholders' Views on Benefits and Challenges for Public Health Research Data Sharing in Kenya: The Importance of Trust and Social Relations.

Jao I, Kombe F, Mwalukore S, Bull S, Parker M, Kamuya D, Molyneux S, Marsh V.

PLoS One. 2015 Sep 2;10(9):e0135545. doi: 10.1371/journal.pone.0135545. eCollection 2015.

2.

Best Practices for Ethical Sharing of Individual-Level Health Research Data From Low- and Middle-Income Settings.

Bull S, Cheah PY, Denny S, Jao I, Marsh V, Merson L, Shah More N, Nhan le NT, Osrin D, Tangseefa D, Wassenaar D, Parker M.

J Empir Res Hum Res Ethics. 2015 Jul;10(3):302-13. doi: 10.1177/1556264615594606. Review.

3.

Involving Research Stakeholders in Developing Policy on Sharing Public Health Research Data in Kenya: Views on Fair Process for Informed Consent, Access Oversight, and Community Engagement.

Jao I, Kombe F, Mwalukore S, Bull S, Parker M, Kamuya D, Molyneux S, Marsh V.

J Empir Res Hum Res Ethics. 2015 Jul;10(3):264-77. doi: 10.1177/1556264615592385.

4.

Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies.

Hamers RL, Sigaloff KC, Wensing AM, Wallis CL, Kityo C, Siwale M, Mandaliya K, Ive P, Botes ME, Wellington M, Osibogun A, Stevens WS, Rinke de Wit TF, Schuurman R; PharmAccess African Studies to Evaluate Resistance (PASER)..

Clin Infect Dis. 2012 Jun;54(11):1660-9. doi: 10.1093/cid/cis254. Epub 2012 Apr 3.

PMID:
22474222
5.

Short communication: High prevalence of transmitted antiretroviral drug resistance among newly HIV type 1 diagnosed adults in Mombasa, Kenya.

Sigaloff KC, Mandaliya K, Hamers RL, Otieno F, Jao IM, Lyagoba F, Magambo B, Kapaata A, Ndembi N, Rinke de Wit TF.

AIDS Res Hum Retroviruses. 2012 Sep;28(9):1033-7. doi: 10.1089/AID.2011.0348. Epub 2012 Feb 2.

PMID:
22149307
6.

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.

Hamers RL, Wallis CL, Kityo C, Siwale M, Mandaliya K, Conradie F, Botes ME, Wellington M, Osibogun A, Sigaloff KC, Nankya I, Schuurman R, Wit FW, Stevens WS, van Vugt M, de Wit TF; PharmAccess African Studies to Evaluate Resistance (PASER)..

Lancet Infect Dis. 2011 Oct;11(10):750-9. doi: 10.1016/S1473-3099(11)70149-9. Epub 2011 Jul 27.

PMID:
21802367
7.

Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific.

Hamers RL, Oyomopito R, Kityo C, Phanuphak P, Siwale M, Sungkanuparph S, Conradie F, Kumarasamy N, Botes ME, Sirisanthana T, Abdallah S, Li PC, Ngorima N, Kantipong P, Osibogun A, Lee CK, Stevens WS, Kamarulzaman A, Derdelinckx I, Chen YM, Schuurman R, van Vugt M, Rinke de Wit TF; PharmAccess African PASER and TREAT Asia Studies to Evaluate Resistance..

Int J Epidemiol. 2012 Feb;41(1):43-54. doi: 10.1093/ije/dyq192. Epub 2010 Nov 10. No abstract available.

8.

Secrecy, disclosure and accidental discovery: perspectives of diaphragm users in Mombasa, Kenya.

Okal J, Stadler J, Ombidi W, Jao I, Luchters S, Temmerman M, Chersich MF.

Cult Health Sex. 2008 Jan;10(1):13-26.

PMID:
18038278
9.

Acceptability of the diaphragm in Mombasa Kenya: a 6-month prospective study.

Luchters S, Chersich MF, Jao I, Schroth A, Chidagaya S, Mandaliya K, Temmerman M.

Eur J Contracept Reprod Health Care. 2007 Dec;12(4):345-53.

PMID:
17853168
10.

Use of self home-made diaphragm for protection against pregnancy and sexually-transmitted infections: case report.

Schroth A, Luchters S, Chersich MF, Jao I, Temmerman M.

East Afr Med J. 2007 Jan;84(1):35-7.

PMID:
17633583

Supplemental Content

Loading ...
Support Center